Clinical Trial Update: The Effect of Consecutive Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examining the effect of consecutive fecal microbiota transplantation on non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Leiden University Medical Center | Conditions: NAFLD | Phase 4 | Status: UNKNOWN